APT(SH:688617) Sou Hu Cai Jing·2025-09-06 17:40Core Insights - Huatai Medical (688617) saw its stock price rise by 8.82% to 309.44 CNY as of September 5, 2025, with a market cap of 43.635 billion CNY, ranking 4th in the medical device sector [1][7] - A significant block trade occurred on September 3, 2025, at a discount of 21.31%, totaling 163 million CNY [2][7] Trading Information - On September 3, 2025, Huatai Medical executed a block trade with a total transaction value of 163 million CNY, at a price 21.31% lower than the closing price [2][7] Shareholder Changes - Shenzhen Mindray Technology Holdings Co., Ltd. increased its stake by acquiring 655,500 shares on September 3, 2025, raising its total ownership to 25.00% [3][7] Executive Changes - Yuchen Qiu, the Vice President, retired on September 1, 2025, and will no longer be recognized as a core technical personnel, although he will serve as a technical advisor [5][7] - The company's R&D team size has shown a steady increase, with 514 members as of June 30, 2025, indicating a stable technical system [5]